Taubman Prize Nomination Period Open

Biomedical researchers worldwide are invited to apply for the Taubman Prize, which recognizes and rewards translational research that has made a significant difference to patient care. The awardee will receive $100,000 and be hosted for a two-day visiting professorship to the University of Michigan in Ann Arbor. Deadline for nominations is February 1; the recipient…

Refining drug therapy for transplant patients

Organ transplants are lifesaving medical miracles for more than 30,000 people per year in the United States – but they come with potentially serious side effects. Drugs that suppress the immune system keep the body from rejecting the donated organ, but they also lower the patient’s ability to fight off infections. Immune suppression can increase…

First TIIPs grant to support immunology research

A team of U-M researchers is launching a new study to better understand autoimmune skin diseases and why some people respond better than others to treatment. In the process, they aim to derive new knowledge about the immune response that could lead to more targeted, personalized therapies for a wider array of disorders. Dubbed PerMIPA,…

Taubman Scholar awarded $6.5M to explore precision oncology

Taubman Scholar and Rogel Cancer Center researcher Arul Chinnaiyan, MD, PhD, has received an Outstanding Investigator Award from the National Cancer Institute, which provides $6.5 million in funding over seven years. The grant will fund research to create new bioinformatics resources and identify new cancer biomarkers to improve diagnosis and ultimately to develop new targeted…

Venneti appointed as newest Emerging Scholar

Deciphering the biology of cancerous tumors is the passion of Sriram Venneti, MD, PhD, the latest recipient of a Taubman Institute research grant. Dr. Venneti, a neuropathologist and assistant professor at Michigan Medicine, has been appointed as the Julia Reyes Taubman Emerging Scholar. This scholarship was created in memory of Ms. Taubman — wife of…

Taubman Scholar John M. Carethers, MD, takes helm of physicians’ group

John M. Carethers, MD, MACP, has begun his term as president of the Association of American Physicians (AAP).  The association is a nonprofit, professional organization founded in 1885 for “the advancement of scientific and practical medicine.” The association is composed of members who are leading senior physician scientists and are competitively selected. Dr. Carethers is…

Lab study may power new treatment to correct crossed eyes

By learning how zebrafish regenerate their eye muscles, researchers could help figure out how to help humans do the same. University of Michigan Kellogg Eye Center (link is external) researchers have published findings in PLOS One (link is external) on the role of insulin-like growth factor (IGF) in promoting extraocular muscle repair and regeneration in zebrafish. If the process…

New TI grants to take research to patient clinics

  Taubman Institute Innovation Projects: Understanding patient differences Why does disease develop and progress differently from person to person, and how can doctors adjust treatments accordingly? A new Taubman Institute grant program aims to help answer such questions by funding projects that will gather data and samples from U-M patients and, eventually, translate that knowledge…

Emerging Scholar hailed for social media prowess

Rajesh Rao, MD, a Taubman Emerging Scholar who uses the Twitter handle @SurgeonRetina, has been invited by the editor-in-chief of the journal Ophthalmology to assist with its social media presence.  Dr. Rao, who specializes in diseases of the eye, has been using the platform since 2015 and has accumulated more than 1,300 followers with his…

Emerging Scholar tapped for featured lecture

Johann Gudjonsson, MD, PhD, has been selected to deliver the “Rising Star” lecture at the International Investigative Dermatology conference in May. Rising Star lectures celebrate the best of emerging dermatological science throughout the world; prominent young researchers engaged in high-impact science are invited to provide a short overview on their current work.   Dr. Gudjonsson is the…